Pharmacy Clinical Pearl of the Day: PrEP for HIV

Article

Truvada is a medicine people at risk for HIV should take to prevent infection with the virus from various ways, such as sex or injection drug use.

Clinical Pearl of the Day: PrEP for HIV

  • Emtricitabine and tenofovir disoproxil fumarate (Truvada) for pre-exposure prophylaxis (PrEP) is a once-daily prescription medicine for adults and adolescents at risk of HIV who weigh at least 77 pounds.

Explanation

  • Truvada is a medicine people at risk for HIV should take to prevent infection with the virus from various ways, such as sex or injection drug use.
  • PrEP consists of a combination of 2 antiretroviral drugs (tenofovir and emtricitabine), usually taken daily and often in combination with other HIV medicines.
  • When taken consistently, the Centers for Disease Control and Prevention estimates that PrEP reduces the risk of HIV infection by up to 92%.

Reference

Related Videos
pharmacy oncology, Image Credit: © Konstantin Yuganov - stock.adobe.com
Mayo Clinic oncology pharmacy
Testicular cancer and prostate cancer concept. | Image Credit: kenchiro168 - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.